Criticizing the high-cost of the life-saving medication

The price of insulin in America has been a much-debated topic, with many people criticizing the high cost of the life-saving medication. Studies have shown that the price of insulin has more than tripled over the last 20 years, with some brands costing upwards of $300 per vial. Patients with diabetes who do not have insurance or whose insurance does not cover the cost of insulin often struggle to afford it, leading to rationing and serious health complications. This has led to calls for reform in the pharmaceutical industry and greater access to affordable healthcare for all Americans. All lives matter more than insulin revenue.